Author:
Fekete Natalie,Gadelorge Mélanie,Fürst Daniel,Maurer Caroline,Dausend Julia,Fleury-Cappellesso Sandrine,Mailänder Volker,Lotfi Ramin,Ignatius Anita,Sensebé Luc,Bourin Philippe,Schrezenmeier Hubert,Rojewski Markus Thomas
Subject
Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy
Reference71 articles.
1. Multilineage potential of adult human mesenchymal stem cells;Pittenger;Science,1999
2. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement;Dominici;Cytotherapy,2006
3. Defining the risks of mesenchymal stromal cell therapy;Prockop;Cytotherapy,2010
4. EMA. The European Agency for the Evaluation of Medicinal Products. Guideline on the Requirements and Controls Applied to Bovine Serum Used in the Production of Immunological Veterinary Medicinal Products. 2002a;EMEA/CVMP/743/00.
5. EMA. The European Agency for the Evaluation of Medicinal Products. Note for Guidance on the Use of Bovine Serum in the Manufacture of Human Biological Medicinal Products (Draft). 2002b;CPMP/BWP/1793/02.
Cited by
240 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献